Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

There are errors in some of the authors’ affiliations. Please refer to the correct affiliations below:

Dr. Laura Caggiari, Dr. Mariangela De Zorzi and De Re Valli:

Bio-Proteomics Core Facility, Experimental and Clinical Pharmacology, Department of Translational Research (molecular oncology, advanced diagnostics and cell therapies)

Dr Toffoli Giuseppe and Dr. Erika Cecchin:

Experimental and Clinical Pharmacology Unit, Department of Translational Research (molecular oncology, advanced diagnostics and cell therapies).

Reference

  1. 1. De Re V, Caggiari L, De Zorzi M, Talamini R, Racanelli V, et al. (2014) Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy. PLoS ONE 9(1): e84940

Citation: The PLOS ONE Staff (2014) Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy. PLoS ONE 9(8): e105850. https://doi.org/10.1371/journal.pone.0105850

Published: August 11, 2014

Copyright: © 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.